Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm
- PMID: 16737965
- PMCID: PMC2430869
- DOI: 10.1074/jbc.M603659200
Visual and both non-visual arrestins in their "inactive" conformation bind JNK3 and Mdm2 and relocalize them from the nucleus to the cytoplasm
Abstract
Arrestins bind active phosphorylated G protein-coupled receptors, terminating G protein activation. Receptor-bound non-visual arrestins interact with numerous partners, redirecting signaling to alternative pathways. Arrestins also have nuclear localization and nuclear exclusion signals and shuttle between the nucleus and the cytoplasm. Constitutively shuttling proteins often redistribute their interaction partners between the two compartments. Here we took advantage of the nucleoplasmic shuttling of free arrestins and used a "nuclear exclusion assay" to study their interactions with two proteins involved in "life-and-death" decisions in the cell, the kinase JNK3 and the ubiquitin ligase Mdm2. In human embryonic kidney 293 cells green fluorescent protein (GFP)-JNK3 and GFP-Mdm2 predominantly localize in the nucleus, whereas visual arrestin, arrestin2(Q394L) mutant equipped with the nuclear exclusion signal, and arrestin3 localize exclusively to the cytoplasm. Coexpression of arrestins moves both GFP-JNK3 and GFP-Mdm2 to the cytoplasm. Arrestin mutants "frozen" in the basal conformation are the most efficacious. Thus, arrestins in their basal state interact with JNK3 and Mdm2, suggesting that arrestins are likely "preloaded" with their interaction partners when they bind the receptor. Robust interaction of free arrestins with JNK3 and Mdm2 and their ability to regulate subcellular localization of these proteins may play an important role in the survival of photoreceptors and other neurons, as well as in retinal and neuronal degeneration.
Figures
Similar articles
-
Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites.J Neurochem. 2007 Nov;103(3):1053-62. doi: 10.1111/j.1471-4159.2007.04842.x. Epub 2007 Aug 6. J Neurochem. 2007. PMID: 17680991 Free PMC article.
-
Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2.J Biol Chem. 2002 Oct 4;277(40):37693-701. doi: 10.1074/jbc.M207552200. Epub 2002 Aug 6. J Biol Chem. 2002. PMID: 12167659
-
Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus.J Biol Chem. 2003 Mar 28;278(13):11648-53. doi: 10.1074/jbc.M208109200. Epub 2003 Jan 21. J Biol Chem. 2003. PMID: 12538596
-
Beta-arrestin and Mdm2, unsuspected partners in signaling from the cell surface.Sci STKE. 2001 Nov 27;2001(110):pe41. doi: 10.1126/stke.2001.110.pe41. Sci STKE. 2001. PMID: 11724970 Review.
-
Overview of different mechanisms of arrestin-mediated signaling.Curr Protoc Pharmacol. 2014 Dec 1;67:2.10.1-2.10.9. doi: 10.1002/0471141755.ph0210s67. Curr Protoc Pharmacol. 2014. PMID: 25446289 Free PMC article. Review.
Cited by
-
The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review.Biomolecules. 2024 Feb 19;14(2):243. doi: 10.3390/biom14020243. Biomolecules. 2024. PMID: 38397480 Free PMC article. Review.
-
GPCR targeting of E3 ubiquitin ligase MDM2 by inactive β-arrestin.Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2301934120. doi: 10.1073/pnas.2301934120. Epub 2023 Jul 3. Proc Natl Acad Sci U S A. 2023. PMID: 37399373 Free PMC article.
-
GPCR Binding and JNK3 Activation by Arrestin-3 Have Different Structural Requirements.Cells. 2023 Jun 6;12(12):1563. doi: 10.3390/cells12121563. Cells. 2023. PMID: 37371033 Free PMC article.
-
GPCR binding and JNK3 activation by arrestin-3 have different structural requirements.bioRxiv [Preprint]. 2023 May 1:2023.05.01.538990. doi: 10.1101/2023.05.01.538990. bioRxiv. 2023. Update in: Cells. 2023 Jun 06;12(12):1563. doi: 10.3390/cells12121563. PMID: 37205393 Free PMC article. Updated. Preprint.
-
β-Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives.Pharmacol Rev. 2023 Sep;75(5):854-884. doi: 10.1124/pharmrev.121.000302. Epub 2023 Apr 7. Pharmacol Rev. 2023. PMID: 37028945 Free PMC article. Review.
References
-
- Carman CV, Benovic JL. Curr. Opin. Neurobiol. 1998;8:335–344. - PubMed
-
- Lefkowitz RJ, Shenoy SK. Science. 2005;308:512–517. - PubMed
-
- Gurevich EV, Benovic JL, Gurevich VV. Neuroscience. 2002;109:421–436. - PubMed
-
- Gurevich EV, Benovic JL, Gurevich VV. J. Neurochem. 2004;91:1404–1416. - PubMed
-
- Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ. Science. 1999;283:655–661. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials